Maravai LifeSciences Holdings, Inc. (MRVI) vs Sarepta Therapeutics, Inc. (SRPT)
Maravai LifeSciences Holdings, Inc. and Sarepta Therapeutics, Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and Sarepta Therapeutics, Inc. are of similar size ($2.0B and $2.0B). Maravai LifeSciences Holdings, Inc. grew revenue faster over the last twelve months: −5.03% against −20.4%. Sarepta Therapeutics, Inc. has the higher net margin (−6.93% vs −37.1%) and the higher return on invested capital (−5.64% vs −15.8%). Across the 18 metrics below, Sarepta Therapeutics, Inc. leads on 13 and Maravai LifeSciences Holdings, Inc. on 5.
Valuation
Profitability
| Metric | MRVI | SRPT | Biotechnology median |
|---|---|---|---|
| Gross margin | 34.89% | 59.09% | 65.16% |
| Operating margin | (56.08%) | (7.26%) | 0.00% |
| Net margin | (37.07%) | (6.93%) | 0.00% |
| Free cash flow margin | (17.17%) | 3.80% | 0.00% |
| Return on equity | (18.79%) | (9.48%) | (57.72%) |
| Return on assets | (10.31%) | (3.98%) | (49.22%) |
| Return on invested capital | (15.83%) | (5.64%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack